Lorazepam Dosing for Acute Seizures and Status Epilepticus
For status epilepticus in adults, administer lorazepam 4 mg IV slowly (2 mg/min), and if seizures continue after 10-15 minutes, give an additional 4 mg dose. This is the FDA-approved dosing and represents the standard of care for terminating status epilepticus 1.
Adult Dosing Protocol
Status Epilepticus (First-Line Treatment)
- Initial dose: 4 mg IV administered at 2 mg/min 1
- Repeat dose: 4 mg IV if seizures continue or recur after 10-15 minute observation period 1
- Maximum total: 8 mg (experience with further doses is very limited) 1
Critical point: The 0.1 mg/kg dosing recommendation (maximum 4 mg) commonly cited in guidelines translates to 4 mg for most adults. However, underdosing lorazepam is extremely common and associated with worse outcomes 2. A 2023 study found that 87% of patients receiving less than 4 mg progressed to refractory status epilepticus, compared to only 62% who received the full 4 mg dose (p=0.03) 2.
Alternative Routes When IV Access Unavailable
- IM route: 0.05-0.1 mg/kg (maximum 4 mg) 3
- Not preferred for status epilepticus due to slower onset
- May be useful when IV access is delayed 1
Pediatric Dosing
Status Epilepticus in Children
Convulsive status epilepticus:
- Initial: 0.1 mg/kg IV (maximum 2 mg per dose) 4
- Repeat after at least 1 minute if needed (maximum 2 doses) 4
- Maintenance: 0.05 mg/kg IV (maximum 1 mg) every 8 hours for 3 doses 4
Non-convulsive status epilepticus:
- Initial: 0.05 mg/kg IV (maximum 1 mg) 4
- Repeat every 5 minutes as needed (maximum 4 doses) 4
- Maintenance: 0.05 mg/kg IV (maximum 1 mg) every 8 hours for 3 doses 4
Critical Safety Considerations
Respiratory Depression Risk
Equipment for airway management must be immediately available before administering lorazepam 1. The most important risk is respiratory depression, particularly when:
- Combined with other sedative agents 3, 1
- Multiple doses are given 1
- Used in elderly patients (>50 years) who experience more profound sedation 1
Administration Technique
- Must dilute with equal volume of compatible diluent before IV use 1
- Inject slowly with repeated aspiration 1
- Stop immediately if patient complains of pain (suggests intra-arterial injection or extravasation) 1
Evidence Supporting This Dosing
The landmark 1998 Veterans Affairs Cooperative Study demonstrated lorazepam's superiority: 64.9% success rate with lorazepam 0.1 mg/kg versus 43.6% with phenytoin alone (p=0.002) 5. A 2001 out-of-hospital study confirmed that lorazepam 2 mg terminated status epilepticus in 59.1% of patients versus 21.1% with placebo (p=0.001) 6.
Common Pitfalls to Avoid
Underdosing is the most common error: Studies show 77-97% of patients receive inadequate doses 2, 7. For adults >40 kg, give the full 4 mg dose.
Delayed second dose: If seizures persist after 10-15 minutes, don't hesitate to give the second 4 mg dose 1.
Failure to prepare for respiratory support: Have bag-valve-mask and intubation equipment ready before administration 1.
Not following with long-acting anticonvulsant: Lorazepam's anticonvulsant effect lasts only 15-20 minutes due to rapid redistribution 3. Immediately follow with phenytoin/fosphenytoin, levetiracetam, or valproate 8, 9.
When Lorazepam Fails
If seizures continue after appropriate lorazepam dosing, immediately administer second-line agents: fosphenytoin, levetiracetam, or valproate (all have similar efficacy) 9. For refractory status epilepticus, consider anesthetic doses of midazolam or propofol 8.